Clinical Trials Browser

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

NCT00052208 2020-10-30

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

Phase 1/2 Completed

158 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00027625 2018-06-27

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Phase 1 Completed

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00025675 2018-06-26

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Phase 2 Completed

105 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Phase 1/2 Completed

61 enrolled 8 charts

CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

NCT00042991 2014-05-28

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Phase 1/2 Completed

69 enrolled 27 charts

CNSSarcoma

Untreated Childhood Anaplastic Astrocytoma

NCT00014170 2013-07-16

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

92 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00016991 2013-06-20

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2 Completed

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase NA Completed

40 enrolled

CNSEndocrineHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

NCT00238251 2012-06-05

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Phase 2 Completed

59 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00132158 2012-04-17

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

19 enrolled

CNSSarcoma

Glioblastoma, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma

NCT00238797 2011-01-21

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Phase 2 Completed

36 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

Phase 2 Completed

23 enrolled

CNS

Neoplasms, Neuroblastoma

Clinical Trials

BM

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Therapy for Children With Neuroblastoma